STAT3 and plasma cell myeloma: Notably, STAT3 activation is associated with the severity of wasting in both the C‐26 and Apcmin/+ models of cancer cachexia, and AR‐42 was previously shown to suppress the IL‐6/GP130/STAT3 signaling axis in multiple myeloma cells (Zhang et al, 2011).